SYNGAP1 FOUNDATION

Lobbying Spend

—

Filings

Firms Hired

Active Period

2022–2025

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2025	—	1	1
2024	—	4	1
2023	—	4	1
2022	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BUCHANAN INGERSOLL & ROONEY PC	—	12

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Food & Drug Administration (FDA)	10
HOUSE OF REPRESENTATIVES	10
Health & Human Services, Dept of (HHS)	10
SENATE	10

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	11
Health Issues	Health Issues	11

SYNGAP1 FOUNDATION — Lobbying Disclosure | Poliscope